Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / BWAY - BrainsWay gets FDA clearance for Deep TMS protocol in major depressive disorder treatment


BWAY - BrainsWay gets FDA clearance for Deep TMS protocol in major depressive disorder treatment

BrainsWay (BWAY) announces that the U.S. FDA has granted 501k clearance for the company’s Theta Burst three-minute protocol utilizing its proprietary Deep Transcranial Magnetic Stimulation ((Deep TMS)) system for the treatment of major depressive disorder ((MDD)).The BrainsWay Theta Burst protocol will be immediately available on all BrainsWay systems already installed, the company said.Shares up more than 1% premarket.

For further details see:

BrainsWay gets FDA clearance for Deep TMS protocol in major depressive disorder treatment
Stock Information

Company Name: BrainsWay Ltd.
Stock Symbol: BWAY
Market: NYSE
Website: brainsway.com

Menu

BWAY BWAY Quote BWAY Short BWAY News BWAY Articles BWAY Message Board
Get BWAY Alerts

News, Short Squeeze, Breakout and More Instantly...